Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarence Yapp

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2026
Modeling development of tertiary lymphoid structures in pulmonary tuberculosis by 3D profiling and trajectory analysisEmmanuel C Ogbonna, Soheil R Talemi, Zoltan Maliga, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Universal consensus 3D segmentation of cells from 2D segmented stacksFelix Y Zhou, Zach Marin, Clarence Yapp, et al.
Nature Methods|November 11, 2025
Universal consensus 3D segmentation of cells from 2D segmented stacksFelix Y Zhou, Zach Marin, Clarence Yapp, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2017
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7Philip A Gerken, Jamie R Wolstenhulme, Anthony Tumber, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.
Nature Communications|May 20, 2020
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Doga C Gulhan, Julia Casado, et al.
Nature Communications|March 21, 2020
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Doga C Gulhan, Julia Casado, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|June 12, 2026
Modeling development of tertiary lymphoid structures in pulmonary tuberculosis by 3D profiling and trajectory analysisEmmanuel C Ogbonna, Soheil R Talemi, Zoltan Maliga, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Universal consensus 3D segmentation of cells from 2D segmented stacksFelix Y Zhou, Zach Marin, Clarence Yapp, et al.
Nature Methods|November 11, 2025
Universal consensus 3D segmentation of cells from 2D segmented stacksFelix Y Zhou, Zach Marin, Clarence Yapp, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2017
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7Philip A Gerken, Jamie R Wolstenhulme, Anthony Tumber, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.
Nature Communications|May 20, 2020
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Doga C Gulhan, Julia Casado, et al.
Nature Communications|March 21, 2020
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Doga C Gulhan, Julia Casado, et al.
Pageof 7